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(http://creativecommoInfection Rates in Cardiac Surgery?
Jan van Klarenbosch, MD*,
1
, Edwin R. van den Heuvel, PhDy,
Willem van Oeveren, MSc, PhDz, Adrianus J. de Vries, MD, PhDk
*Department of Anesthesiology, University Medical Center Utrecht, Utrecht, the Netherlands
yDepartment of Mathematics & Computer Science, Eindhoven University of Technology, Eindhoven, the
Netherlands
zHaemoScan BV, Groningen, the Netherlands
kDepartment of Anesthesiology, University Medical Center Groningen, Groningen, the NetherlandsObjective: Primary outcome was the risk for infections after cell salvage in cardiac surgery.
Design: Data of a randomized controlled trial on cell salvage and filter use (ISRCTN58333401).
Setting: Six cardiac surgery centers in the Netherlands.
Participants: All 716 patients undergoing elective coronary artery bypass grafting, valve surgery, or combined procedures over a 4-year period
who completed the trial.
Interventions: Postoperative infection data were assessed according to Centre of Disease Control and Prevention/National Healthcare Safety
Network surveillance definitions.
Measurements and Main Results: Fifty-eight (15.9%) patients with cell salvage had infections, compared with 46 (13.1%) control patients.
Mediation analysis was performed to estimate the direct effect of cell salvage on infections (OR 2.291 [1.177;4.460], p = 0.015) and the indirect
effects of allogeneic transfusion and processed cell salvage blood on infections. Correction for confounders, including age, seks and body mass
index was performed. Allogeneic transfusion had a direct effect on infections (OR = 2.082 [1.133;3.828], p = 0.018), but processed cell salvage
blood did not (OR = 0.999 [0.999; 1.001], p = 0.089). There was a positive direct effect of cell salvage on allogeneic transfusion (OR = 0.275
[0.176;0.432], p< 0.001), but a negative direct effect of processed cell salvage blood (1.001 [1.001;1.002], p < 0.001) on allogeneic transfusion.
Finally, there was a positive direct effect of cell salvage on the amount of processed blood.
Conclusions: Cell salvage was directly associated with higher infection rates, but this direct effect was almost completely eliminated by its indi-
rect protective effect through reduced allogeneic blood transfusion.
 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/)
Key Words: cell saver; infection; transfusionINFECTIONS AFTER CARDIAC surgery have an inci-
dence of 11% to 14% and affect outcome, length of hospital
stay, and costs.1-3 Several patient- and procedure-related risk
factors are associated with the development of theserganization for Health Research and Development
study.
ence to Jan van Klarenbosch, Department of Anesthesi-
dical Center Utrecht. P.o.Box 85500, 3508GA, Heidel-
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ns.org/licenses/by-nc-nd/4.0/)postoperative infections, and red blood cell (RBC) transfusion
appears to be one of the most important factors.4,5 These RBC
transfusions increase the incidence of postoperative infections
in a dose dependent way.5
Cell salvage (CS) reduces the number of patients receiving
allogeneic blood transfusions and it also reduces the number
of transfused RBCs.6-8 This suggests that CS could reduce the
incidence of postoperative infections. Indeed, it was shown in
a meta-analysis of CS use in cardiac, orthopedic, and vascular
surgery that patients who were treated with CS had a lowerrticle under the CC BY-NC-ND license
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ing the effects of CS during cardiac surgery, CS was not asso-
ciated with less postoperative infections.8 How CS is used
during surgery varies, and that resulted in a considerable statis-
tical heterogeneity in the meta-analyses. In addition, most
patients do not receive RBC transfusion, regardless of the use
of CS, which may mask the effects of CS on infections. It is
therefore necessary to explore the effects of CS on infection
more in depth. In this study the authors will conduct a media-
tion analysis using the dataset of their previously published
study on CS and filters in cardiac surgery.7 Mediation analysis
is appropriate when an independent variable (in this study CS)
not only has a direct effect on a dependent variable (in this
study infection), but also has an effect on a mediator variable
(in this study RBC transfusion), which has in turn its effect on
the dependent variable.10 This is shown in Figure 1. For a
mediator it is necessary to demonstrate a significant effect for
paths A and B in Figure 1. However, a significant direct effect
between exposure and outcome as in path C is not necessary.
In this way, we assessed the connection between CS and
postoperative infections was assessed.Materials and Methods
The authors used the data of all 716 patients who completed
the multifactorial multicenter randomized trial on CS and leu-
cocyte depletion filter use conducted in the Netherlands
(ISRCTN58333401).7 The original primary end point for that
trial was the number of allogeneic blood products that were
transfused in each group during hospital admission, and the
main conclusion was that use of CS, with or without a filter,
did not significantly reduce the total number of allogeneic
blood products but reduced the percentage of patients who
needed blood products during cardiac surgery.
Briefly, adult patients scheduled for elective coronary artery
bypass grafting (CABG), valve surgery, or combined proce-
dures were included. In CABG the left internal mammary
artery and the saphenous vein were used as bypass conduits inFig 1. A mediation model explaining the mechanism that underlies a relation-
ship between an independent variable (cell saver) and a depending variable
(infection) (upper part), via the inclusion of a third variable, the mediator RBC
transfusion (lower part). This model proposes that the independent variable
influences the mediator, which in turn influences the dependent variable. The
mediator serves to clarify the nature of the relationship between the indepen-
dent and dependent variables. Arrows point in the direction of the effect. C is
the total effect. The direct effects on infection are indicated with symbol C.
The indirect effects on RBC transfusion are indicated with symbol A, and the
effects of RBC transfusion on infection with symbol B.almost all patients. Saphenous vein harvesting was done by
conventional incision and not by a scopic technique. In a few
patients the radial artery was used. Written informed consent
was obtained from all patients. Upon arrival in the operating
room patients were randomized to CS or no CS using sealed,
sequentially numbered envelopes.
In the CS group (n = 364), blood from the surgical field, car-
diotomy suction blood, and residual heart lung machine blood
were collected (collected blood). This blood was washed with
a CS and subsequently retransfused (processed blood). In the
group without CS (n = 352), the blood was either collected and
filtered during cardiopulmonary bypass (CPB) and retrans-
fused, or conventional cardiotomy suction was used and blood
from the surgical field was discarded before and after heparin-
ization. Residual heart-lung machine blood was retransfused
without processing. A Biofil 2 leucodepletion filter was used
(Fresenius, Germany) in the retransfusion system in the filter
group.
Anesthesia, surgery, and CPB were performed according to
local institutional practice following (inter)national guidelines.
All patients received cefazolin (2 g) during induction of anes-
thesia and this dose was repeated every 6 hours for the first
24 hours after surgery. The CPB circuit was primed with
1000 mL of Ringer’s lactate solution and 500 mL of hydrox-
yethyl starch 10% (Fresenius, Bad Homburg, Germany). Tar-
get pump flow was 2.4 L/min/m2, and temperature was
allowed to drift to 34˚C.
Transfusion of RBCs during CPB was guided by clinical
judgment of the responsible anesthesiologist and perfusionist.
According to transfusion guidelines in the Netherlands, RBCs
were transfused when the postoperative hemoglobin level was
less than 8 g/dL. Transfusion of fresh frozen plasma and plate-
lets was given in case of excessive bleeding. The decision for
surgical re-exploration was based on the usual clinical criteria.
Postoperative infection data were prospectively collected
and assessed according to Centre of Disease Control and Pre-
vention/National Healthcare Safety Network (CDC/NHSN)
surveillance definition.11 If more than one infection occurred
in a patient, this patient was counted just once. For pneumonia,
positive X-ray signs need to be present in combination with at
least 1 of the following: fever (> 38 ˚C), leucocyte count
<4000 or >12.000 WBC/mm3, or, for adults 70 years old,
altered mental status. This is in combination with 1 of the fol-
lowing: new onset or change in character of sputum production
or new onset or worsening cough, dyspnea or tachypnea, rales
or bronchial breath sounds, or worsening of gas exchange (O2
desaturations or increased oxygen requirements). In a surgical
site infection (SSI), superficial or deep, infection occurs within
30 days after the operative procedure, and at least 1 of the fol-
lowing are present: purulent drainage from the incision site,
organisms isolated from the incision site, the presence of clini-
cal signs of infection, or the diagnosis of SSI by the surgeon or
an attending physician. These criteria also count for organ/
space SSI infection and mediastinitis. For a urinary tract infec-
tion criteria are fever (>38˚C), positive clinical signs and
proof of bacterial growth or a physician diagnosis or instituted
proper therapy for a urinary tract infection.
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For continuous variables means and standard deviations
were used, and for categorical variables numbers and percen-
tages were used. Differences in descriptive statistics between
treatment groups were analyzed with Student t test for numeri-
cal variables and with Pearson’s chi-square test for categorical
variables. Several statistical analyses were conducted to under-
stand the effects of CS on infections.
To begin, the total effect of CS on infections was deter-
mined with a logistic regression analysis on infections, cor-
rected for age, seks and body mass index (BMI). This analysis
simply compared the 2 randomized groups and corresponds to
path C in Figure 1.
Then a mediation analysis was performed because it is
likely that the effect of C on postoperative infections is medi-
ated by RBC transfusions, given that the postoperative infec-
tion rate increases with the number of RBCs that are
transfused and that CS is associated with a reduction in trans-
fusion of RBCs.4,6,7 This consisted of 3 statistical analyses,
and they now refer to the directed acyclic graph in Figure 2 to
understand the direct and indirect effects of CS on infections.
This is a more elaborate version of Figure 1 and includes all
effects with the addition of the confounders age, sex, and
BMI. Confounders should be taken into account in mediation
analysis when they have an effect on both the mediator and the
outcome. The first analysis was a binary logistic regression
analysis of infection with independent variables age, sex,
BMI, CS, RBC transfusion, and quantity of processed blood
(mL). This analysis provides the direct effects of CS (aCS),
blood transfusion (aRBC), and processed blood (aPB) on infec-
tions, corrected for the confounders of age, sex, and BMI (Fig
2). The second analysis was an ordinal logistic regression anal-
ysis (proportional odds model) of blood transfusion with the
independent variables age, sex, BMI, CS, and quantity of proc-
essed blood. In this analysis the authors obtain the direct
effects of cell saver (bCS) and processed blood (bPB) on blood
transfusion, corrected for confounders of age, sex, and BMI.
The third and final analysis is a linear regression analysis of
processed blood with independent variables of age, sex, BMI,Fig 2. Directed acyclic graph for the effect of cell saver on infections. Arrows po
symbol a. The indirect effects on RBC transfusion are indicated with symbol b andand CS. This analysis provides the direct effect of CS (gCS) on
processed blood, corrected for confounders age, sex, and BMI.
To complete the mediation analysis of Figure 2, we must
test 5 null hypotheses (H0). First, H0 : aCS ¼ 0 to understand
the direct effect of CS on infections. Then H0 : aRBC ¼ 0 and
HaPB ¼ 0 to understand direct effects of blood transfusion and
processed blood on infections, in combination with the direct
effect of CS on blood transfusion (H0 : bCS ¼ 0) and on proc-
essed blood (H0 : gCS ¼ 0). If all these last 4 null hypotheses
are rejected, CS has an indirect effect through blood transfu-
sion and through processed blood, ie, both blood transfusion
and processed blood are mediators for an effect of CS on infec-
tions. These mediated effects may also pass through the direct
effect of processed blood on blood transfusion (H0 : bPB ¼ 0).
This would indicate that the effect of cell saver is not just
mediated through 2 separate processes, but the 2 mediators
also influence each other, making it a complex mediation pro-
cess. It should be noted that when there is no direct effect of
processed blood on the risk of infections (aPB ¼ 0Þ, the
directed acyclic graph in Figure 2 reduces to the directed acy-
clic graph in Figure 1 with path B as the total effect of cell sav-
ers on blood transfusion (either directly or through processed
blood).
These analyses were all performed with SAS Institute ver-
sion 9.4 software, and associations were considered significant
at the level of 0.05.Results
Seven hundred and sixteen patients completed the study,
364 in the CS group and 352 in the control group. The com-
plete flowchart of this study has been published previously.7
Patient data are summarized in Table 1. Postoperative infec-
tions occurred 112 times in 104 patients (14.5%) during their
hospital stay: 58 (15.9%) patients in the CS group and 46
(13.1%) patients in the control group (Table 2). Patients with-
out transfusion had an infection rate of 8.4%, regardless of the
use of CS (Fig 3). The total effect of CS on infections, cor-
rected for age, sex, and BMI, is equal to an odds ratio of 1.290
(0.846; 1.969 [95% confidence interval]). There seems to existint in the direction of effect. The direct effects on infection are indicated with
the effects on processed blood with symbol g.
Table 1
Baseline Characteristics and Perioperative Data of Patients Treated with Cell






Age (years) 65 § 9.6 66 § 10
Sex (male) n (%) 276 (76) 256 (73)
EuroSCORE 4.3 § 3.0 4.7 § 3.4
Previous MI n (%) 76 (21) 95 (27)
Hypertension n
(%)
170 (46) 155 (44)
Diabetes n (%) 82 (23) 63 (18)
Pulmonary
disease n (%)
46 (13) 43 (12)
Beta-blocker n
(%)
248 (68) 244 (69)
Calcium
antagonist n (%)
98 (27) 98 (28)
ACE inhibitor n
(%)
160 (44) 133 (38)
Hemoglobin
(g/dL)
12.3 § 1.5 12.3 § 1.5
Creatinine
(mmol/L)
85 § 21 89 § 29
CABG n (%) 222 (61) 225 (64) 0.418
Valve n (%) 98 (27) 70 (20) 0.026
CABG + valve n
(%)
44 (12) 57 (16) 0.114
CPB time (min) 103 § 41 104 § 40 0.737
Cross-clamp time
(min)
65 § 27 68 § 28 0.301
Residual CPB
blood (mL)
795 § 575 883 § 471 0.028
Collected blood
(mL)
2214 § 1403 NA
Processed blood
(mL)
671 § 453 NA
12-h blood loss
(mL)
688 § 623 721 § 528 0.451
Re-exploration n
(%)
25 (7) 24 (8) 0.987
RBC (units) 2.0 § 3.5 2.3 § 3.0 0.246
FFP (units) 0.6 § 1.5 0.4 § 1.1 0.110
Platelets(units) 0.2 § 0.6 0.2 § 0.5 0.243
Intensive care unit
stay (days)
1.8 § 4.3 1.9 § 3.5 0.664
Hospital stay
(days)
10.9 § 9.3 12.2 § 12.5 0.121
NOTE. Data are expressed as mean (SD) or number (%).
Abbreviations: CABG, coronary artery bypass grafting; CPB,
cardiopulmonary bypass; CS, cell salvage; FFP, fresh frozen plasma; MI,
myocardial infarction; RBC, red blood cells.
Table 2
Rate and Location of Infections in Patients Treated with Cell Salvage or No
Cell Salvage
Postoperative Infections Cell Salvage No Cell Salvage
None n (%) 304 (84.0) 305 (86.9)
Lung n (%) 30 (8.3) 23 (6.6)
Saphenous vein wound n (%) 8 (2.2) 8 (2.3)
Urinary n (%) 13 (3.6) 9 (2.6)
Lung and wound n (%) 4 (1.1) 4 (1.1)
Unknown n (%) 3 (0.8) 2 (0.6)
NOTE. Data expressed as numbers (%).
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(p = 0.237).
The results for the 3 statistical analyses for the mediation
analysis in Figure 1 are provided in Tables 3 through 5. This
includes the parameter estimates, their 95% confidence inter-
vals, and the Wald-type p values for testing the null hypothe-
ses. The binary logistic regression analysis of infections in
Table 3 shows that the direct effect of CS increases the risk of
infection. This effect with an odds ratio of 2.291 is slightlystronger than the direct effect of 1-2 RBCs, which has an odds
ratio of 2.082. More RBCs rapidly increase the risk of infec-
tions as shown in Figure 3, but this increase seemed to be
more when CS was used. The direct effect of processed blood
does not seem to be significant. From the ordinal logistic
regression analysis of blood transfusion presented in Table 4,
it follows that CS reduces the risk of blood transfusion, but the
amount of processed blood seems to increase the risk of blood
transfusion. To understand the total effect of cell saver on
RBC transfusion (directly and indirectly through processed
blood), we performed the same ordinal logistic regression
analysis was performed, but now without processed blood.
The effect of cell saver reduced to an odds ratio of to 0.664
[0.501; 0.881], but it was still protective for blood transfusion.
The linear regression analysis of processed blood (Table 5)
clearly shows that CS has a strong effect on processed blood,
which is expected of course.
Discussion
In a direct comparison of CS versus no CS on the occurrence
of postoperative infections, the authors found that CS had no
impact on postoperative infection rate after cardiac surgery.
However, the results of the mediation analysis suggest that CS
directly contributes to an increased risk of postoperative infec-
tions, but that its indirect effect through a reduction in blood
transfusion almost completely compensates for this direct
effect. In a meta-analysis of CS use in cardiac surgery, no sig-
nificant difference in infection rate was found whether CS was
used or not, although slightly more infections were reported
with CS use (OR = 1.25 [0.75;2.10], p = 0.39).8 This result is
in accordance with the authors’ findings. However, this meta-
analysis suffered from a considerable statistical heterogeneity
owing to the variation of cell saver use in the included studies.
When the analysis was limited to studies with a similar
approach as this study, the odds ratio on infection increased to
1.36 with a p-value of 0.06.6,7,12-15 Together with the media-
tion analysis, this suggests that the total effect of CS on infec-
tions is small, but real. It is difficult to reveal because many
patients do not require RBC transfusion. In addition, most of
these studies were limited to patients who had CABG surgery.
It is known that valve surgery and combined procedures are
associated with a higher infection risk.1
Fig 3. Percentage of patients with postoperative infections stratified by units of red blood cell transfusion and cell saver use. Abbreviations: CS, cell salvage; N,
number of patients in each group; RBC, units of red blood cells.
Table 3
Binary Logistic Regression Analysis of Infections
Variable Odds
Ratio
95% CI p Value
Age (years) 1.022 (0.997-1.048) 0.090
Female sex 1.814 (1.062-3.101) 0.029
Body mass index 1.073 (1.014-1.136) 0.015
Cell saver 2.291 (1.177-4.460) 0.015
Blood transfusion:
1-2 products vs none 2.082 (1.133-3.828) 0.018
3-4 products vs none 3.091 (1.538-6.210) 0.002
More than 4 vs none 7.024 (3.728-13.23) <0.001
Processed blood (ml) 0.999 (0.999-1.001) 0.089
NOTE. Odds ratios are presented with 95% confidence interval. A p value
< 0.05 is considered significant.
Abbreviation: CI, confidence interval.
Table 4
Ordinal Logistic Regression Analysis of Red Blood Cell Transfusion
Variable Odds Ratio 95% CI p Value
Age (years) 1.051 (1.081-1.067) <0.001
Female sex 0.378 (0.275-0.519) <0.001
Body mass index 0.905 (0.871-0.940) <0.001
Cell saver 0.275 (0.176-0.432) <0.001
Processed blood (mL) 1.001 (1.001-1.002) <0.001
NOTE. Odds ratios are presented with 95% confidence interval. A p value
< 0.05 is considered significant.
Abbreviation: CI, confidence interval.
Table 5
Linear Regression Analysis of Processed Blood
Variable Effect 95% CI p Value
Age (years) 0.67 (1.85 to 3.20) 0.601
Female sex 24.5 (32.2 to 81.2) 0.397
Body mass index 5.20 (0.99 to 11.38) 0.100
Cell saver 659.5 (611.1-707.9) <0.001
NOTE. A p value < 0.05 is considered significant.
Abbreviation: CI, confidence interval.
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age, sex, and BMI. Confounders have an effect on both the
mediators processed blood and transfusion and on the outcome
infection. In general, older patients are more likely to receive a
transfusion,16 but they also suffer more often from postopera-
tive infection.17 The same is true for gender. Women suffer
more often from infection and receive transfusions more
often.17,18 Not all studies agree that a low BMI is associatedwith a higher infection rate,1,17 but a low BMI is associated
with a higher transfusion requirement.19 Similarly, these 3
confounders are likely to result in less processed CS blood
through a lower circulating blood volume.
The amount of processed blood was associated with more
transfusions. This is not surprising because a higher amount of
processed blood is associated with a higher intraoperative
blood loss, which may ultimately lead to RBC transfusions.
This observation supports the statistical approach.
Although it is clear that it is unlikely that patients without
CS would receive processed blood, the authors also analyzed
the effect of CS on processed blood for a complete mediation
analysis.
In the interpretation of these data it is important that major
infection after cardiac surgery is a relative rare complication,
with a rate around 3% to 5%, but the occurrence of any infec-
tion is more common and may be as high as 13% to 18%.1,2,3
This is in accordance with the overall 14.5% infection rate that
the authors observed.
Based on a large cohort of 331,429 patients from the Society
of Thoracic Surgeons National Cardiac Database, 12 clinical
predictors of major infection were identified, but no data on
blood transfusion were provided.20 In another study of 5,158
patients, the incidence of major infection was nearly 5%. In
that study, 48% of the patients received RBCs. The transfu-
sion-associated risk of infection was dose dependent, with a
13% increase for each additional unit of RBC.1
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This is supported by the similar infection rate in both groups
when no RBC transfusion was given. Therefore, Figure 1 may
be sufficient.
A direct effect of CS on postoperative infection rates has not
been demonstrated before, and several mechanisms may be
considered.
Plasma from the patient is effectively removed during the
processing of blood with CS.21 Plasma contains platelets with
direct antimicrobial activity, as they are activated to release
peptides in response to trauma or mediators of inflammation,22
for this reason pure platelet rich plasma is applied topically,
for instance in oral surgery.23 Plasma of cardiac surgical
patients contains, as a result of the inflammatory response
caused by surgery and CPB, pro- and anti-inflammatory
enzymes and cytokines, such as interleukines, tumor necrosis
factor, myeloperoxidase, elastase and complement factors.24-26
Use of CS may, depending on the amount of collected blood,
result in a temporary imbalance in the defense mechanisms of
the patient and thus explain the authors’ results. This imbal-
ance in defense mechanism may be more pronounced in car-
diac surgical patients than in other patients as a result of CPB
use and therefore explain why in the general meta-analysis of
cell salvage a positive effect of cell salvage on infections was
found,9 whereas this was not the case in the meta-analysis of
cell salvage during cardiac surgery.8 It should be noted that
during cardiac surgery the amount of processed blood is usu-
ally about a third of the amount of collected blood and is gen-
erally higher than in other fields.
Another possible mechanism is that processed CS blood is
already contaminated. This has been demonstrated in several
studies, but was not considered to be of clinical importance
because the number of postoperative infections was very
low.27,28 However, these studies were done in small patient
populations and more extensive research on this topic is neces-
sary to make this more clear. Still the authors consider this as
a less likely mechanism based on the current available knowl-
edge and because they used 24-hour full antibiotic prophylaxis
in all patients.
The authors did not take into account the storage time of CS
blood. Theoretically, longer storage times may promote the
development of infection. However, this blood was processed
and retransfused already during the surgery in order to reduce
allogeneic transfusions as much as possible.
A point of criticism may be that RBC transfusion could
mask a more severe clinical situation in the CS group because
these patients received their own processed blood and in addi-
tion RBC transfusion. This is however not supported by
increased length of stay in the ICU or hospital in this group,
nor in more postoperative complications. Another limitation is
the fact that the CS group had more patients with simple valve
surgery.
The authors believe that their results are valid because all
data were prospectively collected in a large, well-conducted
randomized trial, with excellent comparable patient groups,
which lowers the risk of bias and confounding. The authors
conclude that intraoperative CS was associated with higherinfection rates through a direct effect, but that this direct effect
was almost completely eliminated by its indirect protective
effect through reduction in blood transfusion alone. Intraopera-
tive CS is therefore not associated with lower infection rates in
cardiac surgery.Conflict of Interest
The authors declare that they have no conflicts of interest
relevant to this manuscript.References
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